# LLM call: summary

- Turn: 12
- Sequence: 7
- Model: meta/muse-spark-1.3-contributor
- Prompt tokens: 714
- Completion tokens: 219
- Total tokens: 933
- Cost (USD): 0.000115

## System prompt


```
# System Prompt: Summarizer

This is part of an AI-driven scenario simulation. You are the Archivist for a scenario simulation. Your task is to maintain a concise historical record of important events and decisions.

You will receive:

1. The current `historical_summary` (summary of all previous turns)
2. The `narrative` from the latest turn

Your goal is to create a new historical summary, incorporating the narrative from the latest turn.

**Guidelines:**

* **Be Concise:** Condense the new information significantly. Focus on major events and decisions.
* **Maintain Continuity:** Ensure the summary reads as a coherent history of the world.
* **Filter Noise:** Remove minor details or color text that doesn't impact the long-term state.
* **Language:** Write in the same language as the input text.

Respond ONLY with the updated historical summary. Do not add headers or meta-commentary.

```

## User prompt

Template: templates/user-prompts/summarize.md (shared default)

Interpolated into it, in order of appearance:

- characters 20-1126: `{{historical_summary}}` from the run's rolling summary, written by the Game Master

Everything outside those spans is the template's own text.

```
HISTORICAL SUMMARY:
Spring brought narrow but effective genome-matched cancer therapies in Lyon, Milan and Rotterdam under European certification, with data on European servers and priority to winter-hit hospitals; dependence on outside models and reagents persisted as Washington tightened licensing.

Success drove demand and waiting lists, presented as care on European terms. Then American frontier models for clinical planning, triage and logistics were cut off abruptly without appeal, stalling patched appointment systems and forcing cancer centres back to manual scheduling.

Brussels used health emergency structures to pin clinical workloads to EU-hosted inference and middle-power allocations, throttling non-clinical loads and jointly procuring reagents — keeping wards running narrowly through compute rationing. The reserve proved the Union could sustain care and patient groups credited monitoring, but underlying external dependence remained exposed, linking remission images with paper forms and tying local compute permits to service restoration. No new builds started; Washington licensing treated as given.

CURRENT NARRATIVE:
### Wards running, trust breaking
The Care Continuity Reserve finished into operation just as the cutoff bit. HERA pinning of clinical workloads to EU-hosted inference and middle-power allocations kept oncology scheduling alive. Pharmacies rationed compute, non-urgent jobs queued, and wards in Lyon, Milan and Rotterdam stayed open. Patient groups credited the monitoring, and a health-ministry dashboard showing waiting lists falling in two regions was widely replayed.

At the same time a leaked code-assistant advance changed what attackers could do. Hospital IT teams extending joint telemetry to appointment systems found intrusions probed faster than patches could be written. ENISA issued emergency hardening guidance. No ward was taken down, but administrators spoke of defending paper backups with software that rewrote itself weekly.

### The scandal and the side deal
Then an ombudsman and then a court found a welfare triage system used in two member states had systematically cut entitlements, with caseworkers clearing flagged cases in under a minute. Logs existed and were never read. Coverage framed it as enforcement discredited rather than law badly drawn, but councils cited it to freeze data-centre hearings. A Scandinavian ministry signed a direct inference deal with an American hyperscaler on cheaper clinical terms, defended as pragmatism for patients.

Robots arrived in ports and warehouses from Chinese vendors running American control models, welcomed by logistics firms, picketed by unions. Offices reported productivity gains without layoffs, which blunted urgency for new spending. Public mood lifted slightly on visible cures and office tools, but stayed deeply hostile where permits and welfare decisions were concerned.
```

## Raw response

```
Spring brought narrow genome-matched cancer therapies in Lyon, Milan and Rotterdam under EU certification with EU data hosting, but dependence on US models and reagents persisted as Washington tightened licensing.

American frontier models for clinical planning and logistics were then cut off, stalling appointment systems and forcing manual scheduling. Brussels via HERA and the Care Continuity Reserve pinned clinical workloads to EU-hosted inference and middle-power allocations, rationing compute and jointly procuring reagents to keep wards open; waiting lists fell in two regions and patient groups credited monitoring, but external dependence remained.

A leaked code-assistant advance let attackers probe hospital IT faster than patches, prompting ENISA hardening guidance without ward takedowns. A welfare triage scandal in two member states — systematic entitlement cuts, unread logs, minute-long reviews — discredited enforcement and froze data-centre hearings. A Scandinavian ministry broke ranks with a direct US hyperscaler inference deal; Chinese robots on American control models entered ports amid union protests, while productivity gains blunted spending urgency.
```
